HTA83 Economic Evaluations in Relapsed or Refractory (R/R) Follicular Lymphoma (FL): Challenges for Health Technology Assessment (HTA) Submissions
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.1767
https://www.valueinhealthjournal.com/article/S1098-3015(23)04897-0/fulltext
Title :
HTA83 Economic Evaluations in Relapsed or Refractory (R/R) Follicular Lymphoma (FL): Challenges for Health Technology Assessment (HTA) Submissions
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04897-0&doi=10.1016/j.jval.2023.09.1767
First page :
Section Title :
Open access? :
No
Section Order :
11204